Billionaire Profile
Alice Schwartz
Global Rank
#1646

Image: Public domain | via Wikimedia Commons

Alice Schwartz

CEO, Bio-Rad Laboratories
US
Real-Time Net Worth
$2B
As of December 2025
Age
99
Source
Medical devices
Industry
healthcare
Citizenship
US

Biography

Alice Schwartz (1926 – September 25, 2025) was an American businesswoman and entrepreneur. She is best known as the co-founder of Bio-Rad Laboratories, a company specializing in medical devices for the life science research and clinical diagnostics markets. Schwartz, along with her late husband David Schwartz, launched Bio-Rad in 1952 with a modest investment. Throughout her career, she served as a director and researcher. Her innovative spirit and business acumen were instrumental in the company's growth. Her net worth at the time of her death was estimated at $2.0 billion, a testament to her successful career. Her drive and dedication made her a pioneer in the biotechnology industry, and she was recognized as the oldest and richest woman in the United States by Forbes in 2020.

Wealth Over Time

In-Depth Profile

Early Life

Alice Schwartz was born in 1926 in Germany to Jewish parents. Her family fled to the United States during World War II. She graduated from Woodlake High School in 1944 and later attended an intensive course in analytical chemistry at Stanford, which led to a job at Shell Oil. She earned a degree in biochemistry from the University of California, Berkeley, where she met her husband, David Schwartz.

Rise to Success

In 1952, Alice and David Schwartz, using $720 in savings, co-founded Bio-Rad Laboratories in Berkeley, California. Initially, the company produced tools like ion exchange resins for scientific research. Alice played a crucial role in the company's early development, focusing on product development and financial management, while David handled sales and outreach. Bio-Rad went public in 1966 and expanded internationally, becoming a leader in the life science research and clinical diagnostics markets.

Key Business Strategies

Alice Schwartz's strategic vision contributed to Bio-Rad's sustained success. The company focused on innovation, developing and distributing over 10,000 products. Bio-Rad expanded through strategic acquisitions, such as the purchase of Environmental Chemical Specialties in 1975 and RainDance Technologies in 2017, and also through partnerships. The company held its IPO in 1966 and was listed on the American Stock Exchange in 1980, then the New York Stock Exchange in 2008. Her son Norman became CEO and Chairman after her husband died in 2012. In 2022, she stepped down from the board.

Philanthropy

In 2015, the Schwartz family established the Alles Institute for Medical Research, and Alice was actively involved in its planning and funding, also serving as Chairperson.

Career Milestones

1952

Co-founded Bio-Rad Laboratories

Founded the company with her husband, David Schwartz, starting with a small investment and a focus on biochemicals and radiochemicals.

1966

Bio-Rad IPO

Took Bio-Rad public, marking a significant milestone in the company's growth and expansion.

2012

Husband's Passing

David Schwartz passed away, and her son, Norman Schwartz, became CEO and chairman of Bio-Rad.

2015

Established Alles Institute

The Schwartz family established the Alles Institute for Medical Research, with Alice playing an active role.

2022

Stepped down from the Board

Alice Schwartz stepped down from the board of Bio-Rad Laboratories.

2025

Passed Away

Alice Schwartz passed away on September 25, 2025, at age 99.

Philanthropy & Social Impact

Medical Research

Alles Institute for Medical Research

$XB

Supported the planning and funding of the Alles Institute for Medical Research.